Search results for "From ACP Journal Club"


 
Results 71 - 80 of about 131 for "From ACP Journal Club".

Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia | ACP Diabetes Monthly

Combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin was associated with lower HbA1c values, less weight gain, and similar hypoglycemia rates compared to other type 2 diabetes treatment regimens, according

Review: Bariatric surgery increases weight loss and diabetes remission more than nonsurgical treatment | ACP Diabetes Monthly

A meta-analysis of 11 randomized, controlled trials found that bariatric surgery improved several health and diabetes outcomes more than nonsurgical treatment.

A lifestyle intervention did not reduce cardiovascular outcomes in overweight or obese patients with type 2 diabetes | ACP Diabetes Monthly

The Look AHEAD trial randomized more than 5,000 overweight and obese type 2 diabetics to intensive lifestyle intervention or diabetes support and education and found that the intensive group reduced several risk factors, but not the primary outcome.

A single screening for type 2 diabetes in high-risk adults did not reduce mortality over 10 years | ACP Diabetes Monthly

A trial in the United Kingdom randomized 33 primary care practices and 20,000 of their high-risk patients to screening for diabetes or usual care.

February 9, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

June 9, 2017 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

January 8, 2016 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes | ACP Diabetes Monthly

A meta-analysis included five randomized, controlled trials (with more than 28,000 patients) comparing intensive glucose control to standard glucose control in outpatients with stable type 2 diabetes.

In obesity with type 2 diabetes, duodenal-jejunal bypass liners improved weight loss and HbA1c during treatment | ACP Diabetes Monthly

This randomized controlled trial of 77 obese adults with type 2 diabetes found that adding an endoscopic duodenal–jejunal bypass liner to a dietary intervention improved weight loss and HbA1c after 6 months of treatment, but the benefit was not

July 11, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   3   4   5   6   7   8   9   10   11   12   Next